Therapy of non-malignant diseases or disorders with anti-ErbB2 antibodies

Details for Australian Patent Application No. 2003295798 (hide)

Owner Genentech, Inc.

Inventors Brunetta, Paul G.; Sliwkowski, Mark X.

Agent Griffith Hack

Pub. Number AU-B-2003295798

PCT Number PCT/US2003/0373

PCT Pub. Number WO2004/048525

Priority 60/428,027 21.11.02 US

Filing date 21 November 2003

Wipo publication date 18 June 2004

Acceptance publication date 10 September 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/428,027 21.11.02 US

22 July 2004 Application Open to Public Inspection

  Published as AU-B-2003295798

10 September 2009 Application Accepted

  Published as AU-B-2003295798

21 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003295799-Method of fabricating multi-channel devices and multi-channel devices therefrom

2003295797-Stent tissue graft prosthesis